Combined Effects of Plant Sterols with Low Ratio of n-6/n-3 Polyunsaturated Fatty Acids against Atherosclerosis in ApoE^–/^– Mice

Abstract

The effects of low ratio of n-6/n-3 polyunsaturated fatty acids (PUFA) have been clarified against atherosclerosis. Increasing evidence indicated that plant sterols (PS) have a significant cholesterol-lowering effect. This study explored the effects of PS combined with n-6/n-3 (2:1) PUFA on atherosclerosis and investigated the possible mechanism. In ApoE^−/− mice, the milk fat in high fat diets was replaced with n-6/n-3 (2:1) PUFA alone or supplemented with 6% PS for 16 weeks. Results demonstrated that PS combined with PUFA exerted commentary and synergistic effects on ameliorating atherosclerosis, improving lipid metabolism and lipid deposition in liver, and alleviating inflammatory response. These changes were accompanied with decreased serum TC, TG, LDL-C and increased fecal cholesterol efflux, as well as the lower inflammatory cytokine CRP, IL-6, TNF-α. It is suggested that the underlying mechanism of PS combined with n-6/n-3 (2:1) PUFA promoting the fecal cholesterol efflux may be mediated by liver X receptor α/ATP-binding cassette transporter A1 pathway.

Keywords

plant sterols / polyunsaturated fatty acids / atherosclerosis / lipid metabolism / fecal cholesterol / inflammatory response

References

[1] BenjaminEJ, MuntnerP, AlonsoA, et al.. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation, 2019, 139(10): e56-e528

[2] MooreKJ, TabasI. Macrophages in the pathogenesis of atherosclerosis. Cell, 2011, 145(3): 341-355

[3] PedersenTR. The Success Story of LDL Cholesterol Lowering. Circ Res, 2016, 118(4): 721-731

[4] KitamuraA, NodaH, NakamuraM, et al.. Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb, 2011, 8(6): 454-463

[5] SimopoulosAP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood), 2008, 233(6): 674-688

[6] SimopoulosAP. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients, 2016, 8(3): 128

[7] Kris-EthertonP, HarrisWS, HowardB, et al.. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation, 2006, 114(1): 82-96

[8] DuffyVB, LanierSA, HutchinsHL, et al.. Food preference questionnaire as a screening tool for assessing dietary risk of cardiovascular disease within health risk appraisals. J Am Diet Assoc, 2007, 107(2): 237-245

[9] CliftonPM, KeoghJB. A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease. Nutr Metab Cardiovasc Dis, 2017, 27(12): 1060-1080

[10] YangLG, SongZX, YinH, et al.. Low n-6/n-3 PUFA Ratio Improves Lipid Metabolism, Inflammation, Oxidative Stress and Endothelial Function in Rats Using Plant Oils as n-3 Fatty Acid Source. Lipids, 2016, 51(1): 49-59

[11] YangL, SongZ, CaoW, et al.. Effects of diets with different n-6/n-3 fatty acids on cardiovascular risk factors in mice fed high-fat diets. Wei Sheng Yan Jiu, 2016, 45(3): 436-441

[12] LiuHQ, QiuY, MuY, et al.. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats. Nutr Res, 2013, 33(10): 849-858

[13] HanH, YanP, ChenL, et al.. Flaxseed Oil Containing alpha -Linolenic Acid Ester of Plant Sterol Improved Atherosclerosis in ApoE Deficient Mice. Oxid Med Cell Longev, 2015, 2015: 958217

[14] AthyrosVG, KakafikaAI, PapageorgiouAA, et al.. Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors. Nutr Metab Cardiovasc Dis, 2011, 21(3): 213-221

[15] RasRT, GeleijnseJM, TrautweinEA. LDL-cholesterollowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies. Br J Nutr, 2014, 112(2): 214-219

[16] GyllingH, PlatJ, TurleyS, et al.. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. Atherosclerosis, 2014, 232(2): 346-360

[17] Amir ShaghaghiM, AbumweisSS, JonesPJ. Cholesterol-lowering efficacy of plant sterols/stanols provided in capsule and tablet formats: results of a systematic review and meta-analysis. J Acad Nutr Diet, 2013, 113(11): 1494-1503

[18] KatanMB, GrundySM, JonesP, et al.. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc, 2003, 78(8): 965-978

[19] DemontyI, ChanYM, PelledD, et al.. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am J Clin Nutr, 2006, 84(6): 1534-1542

[20] DemontI, EbineN, JiaX, et al.. Fish oil fatty acid esters of phytosterols alter plasma lipids but not red blood cell fragility in hamsters. Lipids, 2005, 40(7): 695-702

[21] RussellJC, EwartHS, KellySE, et al.. Improvement of vascular dysfunction and blood lipids of insulin-resistant rats by a marine oil-based phytosterol compound. Lipids, 2002, 37(2): 147-152

[22] MarttinenM, PaivarintaE, StorvikM, et al.. Plant stanols induce intestinal tumor formation by up-regulating Wnt and EGFR signaling in Apc Min mice. J Nutr Biochem, 2013, 24(1): 343-352

[23] ScheenAJ, KulbertusH. Clinical study of the month. REVERAL and PROVE-IT: confirmation of the concept “the lower, the better” for cholesterol therapy in patients with coronary heart disease. Rev Med Liege, 2004, 59(3): 167-173

[24] LichtensteinAH, DeckelbaumRJ. AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation, 2001, 103(8): 1177-1179

[25] AbdelhamidAS, BrownTJ, BrainardJS, et al.. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev, 2018, 7(7): Cd003177

[26] PottalaJV, GargS, CohenBE, et al.. Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study. Circ Cardiovasc Qual Outcomes, 2010, 3(4): 406-412

[27] MozaffarianD, LemaitreRN, KingIB, et al.. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med, 2013, 158(7): 515-525

[28] ZhangL, GengY, YinM, et al.. Low omega-6/omega-3 polyunsaturated fatty acid ratios reduce hepatic C-reactive protein expression in apolipoprotein E-null mice. Nutrition, 2010, 26(7–8): 829-834

[29] WanJB, HuangLL, RongR, et al.. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation. Arterioscler Thromb Vasc Biol, 2010, 30(12): 2487-2494

[30] YokoyamaM, OrigasaH, MatsuzakiM, et al.. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 2007, 369(9567): 1090-1098

[31] MoghadasianMH, AlsaifM, LeK, et al.. Combination effects of wild rice and phytosterols on prevention of atherosclerosis in LDL receptor knockout mice. J Nutr Biochem, 2016, 33(7): 128-135

[32] MoghadasianMH. Dietary phytosterols reduce probucol-induced atherogenesis in apo E-KO mice. Atherosclerosis, 2006, 188(1): 28-34

[33] NashedB, YeganehB, HayGlassKT, et al.. Antiatherogenic effects of dietary plant sterols are associated with inhibition of proinflammatory cytokine production in Apo E-KO mice. J Nutr, 2005, 135(10): 2438-2444

[34] WeingartnerO, UlrichC, LutjohannD, et al.. Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE^–/– mice. Cardiovasc Res, 2011, 90(3): 484-492

[35] GaraiovaI, MuchovaJ, NagyovaZ, et al.. Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: a pilot study. Nutr J, 2013, 12: 7

[36] NissinenM, GyllingH, VuoristoM, et al.. Micellar distribution of cholesterol and phytosterols after duodenal plant stanol ester infusion. Am J Physiol Gastrointest Liver Physiol, 2002, 282(6): G1009-1015

[37] van der VeldeAE, BrufauG, GroenAK, et al.. Transintestinal cholesterol efflux. Curr Opin Lipidol, 2010, 21(3): 167-171

[38] Lo SassoG, MurzilliS, SalvatoreL, et al.. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab, 2010, 12(2): 187-193

[39] PlatJ, MensinkRP. Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. Faseb J, 2002, 16(10): 1248-1253

[40] PlatJ, NicholsJA, MensinkRP. Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J Lipid Res, 2005, 46(11): 2468-2476

[41] GuiY, YaoS, YanH, et al.. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Cardiovasc Res, 2016, 112(1): 502-514